Hoth Therapeutics receives Nasdaq extension to Dec 26, 2022 to meet $1 bid price rule

Hoth Therapeutics, Inc.

Received Nasdaq extension to regain compliance with minimum bid price, now deadline Dec 26, 2022.
Original compliance period expired June 28, 2022; additional 180 days granted.
No immediate effect on listing or trading of HOTH common stock on Nasdaq.
If bid price does not close at $1.00+ for 10 consecutive business days by Dec 26, delisting may follow.
Company may consider reverse stock split if needed to meet requirement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.